Shengmingyuan

Beijing Shengmingyuan Pharmaceutical Co., Ltd., commonly known as Lifegen, is a prominent Chinese biotechnology company and a key subsidiary of Beijing Shuanglu Pharmaceutical (SL Pharm). Founded in 1994 and headquartered in Beijing's Zhongguancun Life Science Park, the company is a pioneer in the domestic production of gene-engineered biological drugs in China. Its primary business focus is the development and large-scale manufacturing of recombinant protein therapeutics, with its flagship product, Lifegen (recombinant human erythropoietin), being a market leader for the treatment of anemia. The company's portfolio includes a range of hematopoietic and immunomodulatory agents such as G-CSF, GM-CSF, and various interleukins, targeting indications in oncology, hematology, and infectious diseases. Beijing Shengmingyuan operates advanced GMP-certified manufacturing facilities and serves as a core production base for its parent company's broader biological pipeline.